505 Use of Expanded Access at Michigan Medicine and Associations with Neighborhood Factors
OBJECTIVES/GOALS: Socioeconomic status (SES) affects risk of disease and access to therapies. The expanded access (EA) pathway allows for the clinical use of investigational products for patients who have serious illness but no Food and Drug Administration (FDA)-approved therapeutic options. The SES...
Main Authors: | Misty Gravelin, Jeanne Wright, Shokoufeh Khalatbari, Matheos Yosef, Vikas Kotagal |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124004291/type/journal_article |
Similar Items
-
400 Exploring the Diversity of Expanded Access Patients at Michigan Medicine
by: Misty Gravelin, et al.
Published: (2023-04-01) -
2276 Development of the expanded access oversight committee at Michigan Medicine
by: Kevin Weatherwax, et al.
Published: (2018-06-01) -
2489 Perceptions of “translation” and the application of research across disciplines at the University of Michigan
by: Misty Gravelin, et al.
Published: (2018-06-01) -
Adapting an Expanded Access program to enable investigational treatments for COVID-19
by: Elias Samuels, et al.
Published: (2022-01-01) -
Sociodemographic variables associated with risk for diabetic retinopathy
by: Chan Tran N. Nguyen, et al.
Published: (2022-10-01)